CD274 and neoplasm: Analysis of tumor growth showed that the administration of Ad5Δ24 produced mild growth inhibition, whereas treatment with Ad5Δ24-anti-PD-L1-scFv significantly reduced tumor size at day 19 compared to the other treatments (Figure 4B).